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ABSTRACT 
Objective: This study investigated the possible neuroprotective effects of Ginkgo biloba on cerebral ischemia-reperfusion (I/R) injury in 
ovariectomized rats.  
Methods: Rats were randomly allocated into 5 groups as follows: Sham-operated group, Ovariectomized group (OVX), Cerebral I/R injury 
ovariectomized group (OVX+I/R) and two treated groups given Ginkgo biloba leaves extract in two doses [(OVX+I/R)+Gin50 and 
(OVX+I/R)+Gin100] for one month starting one month after ovariectomization. Two months after ovariectomization, cerebral I/R injury was 
induced. 24 h later, blood and brain samples were collected.  
Results: Ginkgo biloba (50 and100 mg/kg) significantly decreased concentrations of TNF-α, MDA and NO, increased GSH concentration in serum 
and brain tissue and improved the histopathological pictures of treated rats when compared to ovariectomized cerebral I/R injury group. The effect 
of Ginkgo biloba high dose was better than the low dose.  
Conclusion: Thus the study suggests Ginkgo biloba as a potent supplement for protection against cerebral I/R injury in estrogen deficient females, 
after full clinical evaluation. The proposed mechanisms include neuroprotective, anti-inflammatory and anti-oxidant actions. 
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INTRODUCTION 
Premenopausal females exhibit a lower susceptibility to many 
cardiovascular and cerebrovascular diseases than males and 
postmenopausal females. This apparent protection is diminished 
and even lost, within ten years of menopause [1]. Brain damage after 
stroke in female animals is less when compared with their age-
matched males, and this beneficial effect disappears with depletion 
of endogenous ovarian steroidal hormones [2]. Neuroprotection in 
premenopausal females may be attributed to higher levels of 
circulating estrogens; principally 17b-estradiol (E2). E2 is the most 
potent endogenously synthesized and secreted ovarian estrogen. 
During aging; neuroinflammation is a common feature of many 
cerebrovascular disorders, and is often associated with the release 
of pro-inflammatory cytokines and chemokines [3]. This 
neuroinflammatory response is referred to as “inflamm-aging” [4]; 
where blood levels of IL-6 and TNF-α significantly increase [5, 6], 
causing chronic subclinical inflammation that may lead to 
neurodegeneration and cognitive decline [7]. In young and middle-
aged ovariectomized rodents, a model used to mimic surgical 
menopause, pro-inflammatory cytokine production increased in 
several injury models in both the central and peripheral nervous 
systems, whereas treatment with E2 attenuated this increase in 
cytokine production [8, 9]. Furthermore, inflammatory changes 
produced during menopause can stimulate innate immune 
responses in the brain and aggravate ischemic damage [10]. Despite 
the fact that the risk of cerebrovascular events rises in women after 
menopause [11], and that the efficacy of postmenopausal estrogen 
replacement therapy (ERT) in stroke prevention is still 
controversial, However, ERT successfully reduces the risk of 
cardiovascular disease [12]. The anti-inflammatory activities of E2 
are mainly mediated in the brain tissue by the estrogen receptors 
(ER); ERα and ERβ [13, 14]. 
Mechanical recanalization or thrombolysis leads to restoration of 
blood flow following ischemic stroke [15]. Unfortunately, reperfusion 
may exacerbate the ischemic injury in some patients, causing what is 
known as “Cerebral Reperfusion Injury”. Cerebral reperfusion injury is 
the deterioration of ischemic but salvageable brain tissue after 
reperfusion [16, 17]. The pathogenesis of this injury includes post-
ischemic hyper-perfusion, destruction of the blood–brain barrier, 
leukocyte infiltration and\or platelet activation [18]. 
Ginkgo (the maidenhair tree) is among the oldest living species of 
trees on earth and that's why it is called the "living fossil". Ginkgo 
belongs to the family Ginkgoaceae that flourished in large forests 
over 150 million years and is currently grown around the world for 
purposes [19]. Ginkgo tree leaves and seeds have been used for 
medicinal purposes since 1509 A. C. In traditional Chinese medicine, 
the extract of Ginkgo leaves has been used to treat circulatory 
disorders, cognitive problems, asthma, tinnitus and vertigo [20]. 
Highly-concentrated and stable extracts from Ginkgo leaves, have 
been extracted and standardized successfully, in the early 1970s by 
Dr. Willmar Schwabe Pharmaceuticals (Karlsruhe, Germany) [21]. 
The constituents of the standardized extract from the leaves of the 
Ginkgo biloba tree, labeled EGb761, are as follows: 24% flavonoid 
glycosides, 6% terpenoids and 5–10% organic acids. The 
pharmacologically active constituents of EGb761 are flavonoids and 
terpenoids [22, 23]. Nowadays, film-coated tablets, oral liquids or 
injectable solutions of EGb761 can be purchased and are one of the 
most commonly taken herbal medicines worldwide [24]. In Germany 
EGb761 has been approved for treatment and prevention of cerebral 
insufficiency, neurodegenerative dementias associated with ageing as 
Alzheimer’s disease, peripheral vascular diseases, intermittent 
claudication, neurosensory problems as tinnitus and vertigo [25, 26]. 
Ginkgo is also called the "Brain Herb," it has been studied for the 
treatment of cerebral atherosclerosis, cerebral insufficiencies and 
depression [27]. The role of EGb761 in neuropsychopharmacology has 
been demonstrated by Dua et al. (2009)[28]. Many studies revealed 
that EGb761 has antioxidant and free radical scavenging effects [29]. 
EGb761 directly attenuates reactive oxygen species (ROS) and 
stabilizes the cellular redox state by up-regulating the activity of 
antioxidant enzymes [30]. Moreover, EGb761 enhances the activity of 
glutathione reductase and gamma-glutamylcysteinyl synthetase, the 
main enzymes essential for reduction and synthesis of glutathione 
(GSH) [31]. Also anti-apoptotic, anti-inflammatory activity [32, 33], 
protection against mitochondrial dysfunction [34, 35], and induction 
of growth factors [36] are proposed mechanisms of action of EGb761.  
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Therefore, the aim of the current study is to elucidate the 
neuroprotective effects of Ginkgo biloba leaves extract (EGb761) on 
cerebral ischemia-reperfusion injury induced experimentally in 
ovariectomized rats.  
MATERIALS AND METHODS 
Animals 
Adult female albino rats, weighing 250-280 g, were used in the 
present study. The animals were obtained from the Animal 
House Colony of National Research Center (Dokki, Cairo, Egypt) 
and were housed under conventional laboratory conditions 
throughout the period of the experimentation. Animals were 
provided with standard laboratory food pellets and tap water ad 
libitum. The study was conducted in accordance with the 
National Research Centre-Medical Research Ethics Committee 
(NRC-MREC) for the use of animal subjects and followed the 
recommendations of the National Institutes of Health Guide for 
Care and Use of Laboratory Animals [37]. 
Rats were anesthetized with thiopental sodium (20 mg/kg; ip) and 
then ovariectomized according to the method described by Turner 
et al. (2000) [38]. Sham-operated control group of animals was also 
included. Drug administration was started one month after 
ovariectomization and continued for another month. 
Drugs 
Ginkgo biloba leaves extract (Ginko capsules®; Arab company for 
pharmaceutical and medicinal plants, MEPACO-MEDIFOOD, Egypt) 
were used in the current study in doses of 50 and 100 mg/kg/day, p. 
o. [39, 40]. All other chemicals were of the highest available 
commercial grade.  
Ovariectomy 
Rats were anesthetized with thiopental sodium (20 mg/kg; i. p.) and 
then ovariectomized according to the method described by Turner 
et al. (2000) [38].  
Cerebral ischemia induction 
Two months after the operation, animals were starved for 12 h 
before surgery and then anesthetized with thiopental (20 mg/kg; i. 
p.). A longitudinal cervical incision (2 cm) was made lateral to the 
midline and the common carotid artery (CCA) was carefully 
dissected. Ischemia was induced by placing nontraumatic 
microvascular clip on left CCA just prior to its bifurcation [41]. 
During ischemia, rats were monitored for body temperature 
constant at 36.5±0.5˚C using a heating pad and respiration pattern. 
The vascular occlusion was maintained for 30 min, and then the 
clips were removed to resume blood flow to the ischemic region for 
24 h [42]. Finally, the incisions were sutured, the animal was 
allowed to recover from anesthesia, and returned to a warm cage for 
recuperation during reperfusion period for 24 h. 
Experimental design  
Rats were randomly allocated into 5 groups (8-12 rats each):  
Group I: Sham-operated rats. 
Group II: Ovariectomized rats [OVX] that received one ml tab water daily 
one month after ovariectomization and continued for another month. 
Group III: Ovariectomized rats that weren't treated and underwent 
cerebral ischemia-reperfusion injury [OVX+I/R] 2 mo after 
ovariectomization. 
Group IV: Ovariectomized rats treated one month after 
ovariectomization with Ginkgo biloba leaves extract (50 mg/kg/day; 
p. o.). Treatment continued for another month followed by cerebral 
ischemia-reperfusion injury [(OVX+I/R)+Gin50]. 
Group V: Ovariectomized rats treated one month after 
ovariectomization with Ginkgo biloba leaves extract (100 
mg/kg/day; p. o.). Treatment continued for another month followed 
by cerebral ischemia-reperfusion injury [(OVX+I/R)+Gin100]. 
Biochemistry 
At the end of the experiment, blood samples were withdrawn from 
the retro-orbital venous plexus of 18 h food-deprived rats. Collected 
blood samples were allowed to stand for 10 min at room 
temperature then centrifuged at 4oC using cooling centrifuge 
(Laborezentrifugen, 2k15, Sigma, Germany) at 3000 r. p. m for 10 
min and sera were separated for the assessment of serum level of 
malondialdehyde (MDA), Nitric oxide (NO) metabolites, tumor 
necrosis factor alpha(TNF-α) expression and reduced glutathione 
(GSH) according to the methods adopted by Ruiz-Larrea et al. 
(1994)[43], Miranda et al.(2001)[44], Brouckaert et al.(1993)[45] 
and Ellman (1959) [46]and modified by Bulaj et al. (1998)[47] 
respectively using commercially available kits (Biodiagnostic, 
Egypt). 
Tissue sampling  
Directly after collecting the last blood sample in the experiment, rats 
were decapitated under light diethyl ether–anesthesia and their 
brain were carefully isolated and dissected through the midline into 
two hemispheres. 0.5g of the affected hemisphere was homogenized 
(using MPW–120 homogenizer, Med instruments, Poland); the 
homogenate was centrifuged using a cooling centrifuge 
(Laborezentrifugen, 2k15, Sigma, Germany) at 3000 r. p. m for 10 
min; the supernatant was taken for the determination of brain level 
of MDA, NO metabolites, TNF-α expression and GSH according to the 
methods adopted by Ruiz-Larrea et al. (1994)[43], Miranda et 
al.(2001)[44], Brouckaert et al.(1993)[45] and Ellman (1959)[46] 
and modified by Bulaj et al.(1998) [47] respectively using 
commercially available kits (Biodiagnostic, Egypt).  
Histopathological examination  
Brain tissues from different groups were immediately fixed in 10% 
neutral buffered formalin and embedded in paraffin wax. 4 µm thick 
sections were stained with Hematoxylin and Eosin (H & E) and 
examined using binocular Olympus CX31 microscope [48].  
Statistical analysis 
All the values are presented as means±standard error of the means 
(SE). Comparisons between different groups were carried out using 
one-way analysis of variance (ANOVA) followed by Tukey’s multiple 
comparison post hoc tests. The difference was considered significant 
when p˂0.05. GraphPad prism®software (version 6.00) was used to 
carry out these statistical tests.  
RESULTS  
Effect of Ginkgo biloba leaves extract on serum biochemical 
parameters 
Cerebral I/R injury in ovariectomized rats resulted in a significant 
elevation in serum concentration of MDA, NO metabolites and TNF-α 
and a significant decrease in serum concentration of GSH when 
compared to either sham-operated or ovariectomized groups. 
Administration of Ginkgo biloba leaves extract (50 and 100 
mg/Kg/day; p. o.) improved all the aforementioned parameters, and 
the effect of high dose was better than the low dose. Ginkgo biloba 
leaves extract (50 mg/Kg/day; p. o.) managed to decrease the 
elevated serum concentration of MDA, NO metabolites and TNF-α to 
71%, 82% and 67% respectively when compared to ovariectomized 
rats undergoing cerebral I/R injury.  
Moreover, Ginkgo biloba leaves extract (50 mg/Kg/day; p. o.) 
succeeded to elevate the diminished serum GSH concentration 
to156 % when compared to ovariectomized rats undergoing 
cerebral I/R injury. While Ginkgo biloba leaves extract (100 
mg/Kg/day; p. o.) managed to decrease the elevated serum 
concentration of MDA, NO metabolites and TNF-α to 66%, 61% 
and 24% respectively when compared to ovariectomized rats 
undergoing cerebral I/R injury. Moreover, Ginkgo biloba leaves 
extract (100 mg/Kg/day; p. o.) succeeded to normalize the 
diminished serum GSH concentration and elevated it to 252 % 
when compared to ovariectomized rats undergoing cerebral I/R 
injury (table 1). 
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Table 1: Effect of Ginkgo biloba leaves extract (50 and 100 mg/Kg/day; p. o.) on serum concentration of GSH, MDA, NO metabolites and 
TNF-α after cerebral ischemia-reperfusion injury in ovariectomized rats 
Groups Serum parameters 
GSH (µmol/ml) MDA (nmol/ml)  )NO (µmol/ml TNF-α (pg/ml) 
Sham-operated 22.02±1.76 119.21±4.99 69.07±2.62 30.32±1.61 
OVX 22.18±1.75 130.77±8.53 72.07±1.64 32.91±1.07 
(OVX+I/R) 0.61±a,b9.41 0.242±a,b5170.3 6.58±a,b,c148.03 4.36±,ba112.73 
(OVX+I/R)+Gin50 14.71±0.57 17.32±a,b,c64.422 5.68±a,b,c120.84 2.22±,b,ca75.01 
(OVX+I/R)+Gin100 2.73±c23.68 9.33±a,b,c44.232 4.68±a,c90.67 1.13±c27.40 
The administration of drugs was started one month after ovariectomization and continued for another month, followed by cerebral ischemia-
reperfusion injury, Data is presented as mean±SE (n=10). aSignificantly different from the sham-operated group at p<0.05 (Tukey’s post hoc test). 
bSignificantly different from OVX group at p<0.05 (Tukey’s post hoc test). cSignificantly different from OVX+I/R group at p<0.05 (Tukey’s post hoc test). 
 
Table 2: Effect of Ginkgo biloba leaves extract (50 and 100 mg/Kg/day; p. o.) on brain tissue concentration of GSH, MDA, NO metabolites 
and TNF-α after cerebral ischemia-reperfusion injury in ovariectomized rats 
Groups Brain tissue parameters 
GSH (µmol/g tissue) MDA (nmol/g tissue) NO (µmol/g tissue) TNF-α (pg/100 mg tissue) 
Sham-operated 6.28±0.31 123.20±3.25 52.91±3.99 151.42±8.21 
OVX ±0.44a.655 130.64±1.99 55.58±4.17 ±4.63a156.56 
(OVX+I/R) ±0.03b4.00 ±1.87a,b168.46 ±5.73a,b153.95 ±5.69a,b,c499.87 
(OVX+I/R)+Gin50 ±0.05a4.50 ±3.03a,b,c146.86 ±6.76a,b,c121.59 ±6.57a,b,c370.63 
(OVX+I/R)+Gin100 ±0.42c6.27 ±1.29c129.04 ±3.37a,b,c86.14 ±9.36a,b65258. 
The administration of drugs was started one month after ovariectomization and continued for another month, followed by cerebral ischemia-reperfusion 
injury, Data is presented as mean±SE (n=10). aSignificantly different from the sham-operated group at p<0.05 (Tukey’s post hoc test). bSignificantly different 
from OVX group at p<0.05 (Tukey’s post hoc test). cSignificantly different from OVX+I/R group at p<0.05 (Tukey’s post hoc test). 
 
Histopathological examination of brain tissue 
 
Fig. 1: Photomicrographs of brain sections (H & E X 200); 
prepared from (A-B) a sham-operated rat showing no 
histopathological alteration and the normal histological structure of 
the meninges, cerebral cortex, hippocampus, striatum, and 
cerebellum were recorded. (C-D) an ovariectomized rat is showing 
minimal alteration in the overall histopathological picture of the 
brain. The normal histological structure of the meninges, cerebral 
cortex, hippocampus, striatum and cerebellum was observed. (E-G) 
an ovariectomized rat where cerebral I/R injury has been 
experimentally induced showing degeneration and nuclear pyknosis 
in the neurons of the cerebral cortex, and in the hippocampus. Focal 
eosinophilic plagues formation was clearly observed in the striatum. 
(H-J) an ovariectomized rat with cerebral I/R injury and treated 
with Ginkgo biloba leaves extract (50 mg/Kg/day; p. o.) showing 
moderate degeneration and nuclear pyknosis in some neurons of the 
cerebral cortex, as well as the hippocampus. Focal gliosis was 
detected in the cerebrum. (I-K) an ovariectomized rat with cerebral 
I/R injury and treated with Ginkgo biloba leaves extract (100 
mg/Kg/day; p. o.) showing an improved overall histopathological 
features where the hippocampal neurons showed normal 
histological structure, while the cerebral cortex showed minimal 
neuronal pyknosis 
Effect of Ginkgo biloba leaves extract on brain tissue parameters 
Cerebral I/R injury after ovariectomization resulted in a significant 
elevation in brain tissue concentration of MDA, NO metabolites and 
TNF-α and a significant decrease in brain tissue concentration of 
GSH when compared to either sham-operated or ovariectomized 
groups. Administration of Ginkgo biloba leaves extract (50 and 100 
mg/Kg/day; p. o.) improved all the aforementioned parameters and 
the effect of high dose was better than the low dose. Ginkgo biloba 
leaves extract (50 mg/Kg/day; p. o.) decreased the elevated brain 
tissue concentration of MDA, NO metabolites and TNF-α to 87%, 
79% and 74% respectively when compared to ovariectomized rats 
undergoing cerebral I/R injury. Moreover, Ginkgo biloba leaves 
extract (50 mg/Kg/day; p. o.) elevated the diminished brain tissue 
GSH concentration to 113% when compared to ovariectomized rats 
undergoing cerebral I/R injury. 
While, Ginkgo biloba leaves extract (100 mg/Kg/day; p. o.) 
normalized the diminished brain tissue GSH concentration and 
decreased the elevated brain tissue concentration of MDA, NO 
metabolites and TNF-α to 77%, 56% and 52% respectively when 
compared to ovariectomized rats undergoing cerebral I/R injury. 
Ginkgo biloba leaves extract (100 mg/Kg/day; p. o.) succeeded to 
normalize the diminished serum GSH concentration and elevated it 
to 157% when compared to ovariectomized rats undergoing 
cerebral I/R injury (table 2). 
DISCUSSION 
In the present study, ovariectomization of rats resulted in the 
elevation of serum and brain tissue concentration of anti-
inflammatory parameters as TNF-α; oxidative stress parameters as 
MDA and NO metabolites and a decrease in antioxidant parameters 
as GSH. These changes are attributable to the loss of the estrogen 
and its evident neuroprotection. Estrogen exerts its neuroprotective 
actions through different mechanisms; the antioxidant free-radical 
scavenging pathway being the most important [49]. The formation 
of ROS in cases of estrogen depletion plays a major role in the 
ischemic damage [50]. Arslan et al. (2011) stated that that 
ovariectomization in rats lead to an elevation in plasma 
concentrations of MDA and NO metabolites [51]. Also, Ozacmak and 
Sayan (2009) added that ovariectomization in rats lead to a decline 
in GSH concentrations along with the elevation in MDA 
concentrations in the striatum, hippocampus, and cortex when 
compared to normal rats [50]. Moreover, ovariectomization caused a 
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minimal change in the histological structure of the brain tissue, and 
the overall histopathological picture of the ovariectomized group 
was normal when compared to the sham-operated group. This data 
is in agreement with Aly et al. (2011) who demonstrated that 
ovariectomized rats showed normal histopathological features [52]. 
The present study showed that cerebral I/R injury induced 
deleterious biochemical changes in serum as well as in the brain 
tissue and caused substantial brain injury. In ovariectomized rats 
undergoing cerebral I/R injury; serum and brain tissue 
concentration of inflammatory parameters as TNF-α; oxidative 
stress parameters as MDA and NO metabolites were significantly 
elevated whereas serum and brain tissue concentration of 
antioxidant parameters as GSH was significantly decreased when 
compared to ovariectomized group. The histopathological picture of 
ovariectomized rats undergoing cerebral I/R injury showed 
degeneration and nuclear pyknosis in the neurons of the cerebral 
cortex and in the hippocampus. Focal eosinophilic plagues formation 
was clearly observed in the striatum. Although significant cerebral 
damage occurs during an ischemic episode, further brain damage 
can occur after blood flow restoration [53].  
Previous studies reported that cerebral I/R injury caused 
deleterious events in young and adult rats [41, 54]. One possible 
mechanism for brain damage that occurs during reperfusion 
involves generation of ROS [55]. Reduced glutathione (GSH) is an 
endogenous antioxidant scavenging free radicals and protecting 
against ROS and oxidative stress. Preserving GSH-mediated 
antioxidant defense is critical for cell survival [56]. Damage to 
membrane lipids, specifically lipolysis during ischemia and free 
radical-mediated peroxidation of polyunsaturated fatty acids during 
reperfusion [57] and MDA production; which is the end product of 
lipid peroxidation, as well as significant increase in its concentration in 
brain tissue leads to many of the outcomes observed in cerebral I/R 
injury [41]. Ozacmak and Sayan reported that MDA concentration in 
brain tissue samples increases significantly in cerebral I/R injury 
accompanied by a significant decrease in GSH levels in the 
hippocampus when compared to the ovariectomized group [50].  
The present study demonstrated that serum and brain levels of NO 
metabolites were significantly elevated in cerebral I/R injury group 
when compared to ovariectomized group. The formation of NO 
metabolites increase in brain injury, where the L-arginine-NO 
pathway is activated by the increased levels of cytokines and 
endotoxins [42]. Morikawa et al.(1992) and Yamamoto et al.(1992) 
demonstrated a significant increase in NO production by cerebral 
vascular endothelial cells, which might have exerted a 
neuroprotective effect in focal cerebral ischemia by increasing blood 
flow to marginally ischemic tissues [58, 59]. 
It has been well established that during brain ischemia, pro-
inflammatory cytokines such as TNF-α, IL-1β, IL-6, are vastly 
produced by different activated cell types as endothelial cells, 
microglia, astrocytes, and neurons [60]. Hindering the production of 
these pro-inflammatory cytokines would be an important approach 
to protecting against ischemic brain injury. In the present study, we 
observed that TNF-α expression was significantly elevated in 
cerebral I/R injury group when compared to ovariectomized group. 
This data is in agreement with Brown et al. (2010) who stated that a 
series of pro-inflammatory cytokines and chemokines are induced in 
cerebral injury [3]. Jin et al. (2015) demonstrated that TNF-α was 
highly expressed in ischemic brain injury in rats and was 
significantly reduced after treatment [61]. Silva et al. (2015) also 
observed marked cytokine and chemokine up-regulation (IL-1 and 
TNF-α) after cerebral I/R injury in mice [62]. 
Administration of Ginkgo biloba leaves extract (50 mg/Kg/day; p. o.) 
significantly decreased the elevated serum and brain tissue 
concentrations of TNF-α, MDA and NO metabolites. It also increased 
serum and brain tissue concentration of GSH when compared to 
ovariectomized cerebral I/R injury group. The histopathological 
picture of rats treated with Ginkgo biloba leaves extract (50 
mg/Kg/day; p. o.) showed moderate degeneration and nuclear 
pyknosis in some neurons of the cerebral cortex as well as the 
hippocampus. Focal gliosis was also detected.  
Ginkgo biloba leaves extract (100 mg/Kg/day; p. o.) improved and 
almost normalized all the biochemical parameters measured in sera 
and brain tissues. Moreover, an improvement in the overall 
histopathological features was noted in rats treated with Ginkgo 
biloba leaves extract (100 mg/Kg/day; p. o.); where the 
hippocampal neurons showed the normal histological structure 
and the cerebral cortex showed minimal neuronal pyknosis. It 
was clear that the effects of the high dose were better than the 
low dose.  
Previous preclinical studies support the hypothesis that Ginkgo 
biloba may be effective in the treatment and prevention of age-
related neurodegenerative disorders [27]. Many studies have 
proposed that the beneficial action of Ginkgo biloba leaves extract 
was mainly due to its free-radical scavenging effect [29]. Wei et 
al.(2000) demonstrated that pretreating cerebellar granule cells with 
Ginkgo biloba effectively caused attenuation of oxidative damage 
triggered by hydrogen peroxide/ferrous sulphate (H2O2/FeSO4) [63]. 
In another study, Ginkgo biloba was found to be able to attenuate the 
basal as well as the induced levels of H2O2-related ROS [60]. In addition 
to the direct reduction of ROS, Ginkgo biloba also stabilized the cellular 
redox state by up-regulation of activity of antioxidant enzymes [30]. 
Ginkgo biloba increased the activity of superoxide dismutase and 
catalase in rat hippocampus [64]. Ginkgo biloba also enhanced the 
activity of two enzymes essential for reduction and synthesis of GSH, 
which are glutathione reductase and gamma-glutamylcysteinyl 
synthetase [31]. The flavonoid fraction of Ginkgo biloba is suggested to 
be mainly responsible for its antioxidant properties [31]. Moreover, 
Ginkgo biloba has been proved to have anti-inflammatory effects. 
These effects may be due to the combined actions of its contents: 
ginkgolide and flavonoid [33]. Ginkgo biloba inhibits the production of 
pro-inflammatory cytokines TNF-α and IL-1 in rats [65]. Other 
mechanisms may also be involved in neuroprotective actions of Ginkgo 
biloba including its anti-apoptotic effect, protection against 
mitochondrial dysfunction, amyloidogenesis, and induction of growth 
factors [27].  
CONCLUSION 
In conclusion, the current study revealed that cerebral ischemia-
reperfusion injury induced severe deleterious serum and brain 
tissue biochemical changes as well as brain histopathological 
changes in ovariectomized rats lacking the neuroprotective features 
of estrogen. Ginkgo biloba leaves extract given in two doses (50 and 
100 mg/kg/day, p. o.) for one month before induction of cerebral 
I/R injury in ovariectomized rats markedly decreased the elevated 
serum and brain tissue concentration of inflammatory parameters 
as TNF-α and serum and brain tissue concentration of oxidative 
stress parameters as MDA and NO metabolites. On the other hand, 
serum and brain tissue concentration of antioxidant parameters as 
GSH was significantly elevated in rats treated with Ginkgo biloba. 
Ginkgo biloba also improved the overall histopathological pictures of 
rats when compared to ovariectomized cerebral I/R injury group. 
Thus the study suggests Ginkgo biloba as a potent protective agent 
against cerebral I/R injury in ovariectomized rats. This may give an 
insight to protection against cerebral I/R injury effects in estrogen 
deficient females either due to reproductive senescence or depletion 
of endogenous estrogens. The proposed neuroprotective 
mechanisms of action of Ginkgo biloba include its anti-inflammatory 
and anti-oxidant actions. 
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